Incyte to Report Second Quarter 2014 Financial Results on July 31

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq: INCY) announced today that it has scheduled its second quarter 2014 financial results conference call for 8:30 a.m. ET on Thursday, July 31, 2014. The schedule for the press release and conference call is as follows: Q2 2014 Press Release: July 31, 2014 at 7:00 a.m. Buy Zyprexa (Olanzapine) without prescription ET Q2 2014 Conference Call: July 31, 2014 at 8:30 a.m. Zyrtec (Cetirizine) with free Rx ET Domestic Dial In Number: 877-407-8037 International Dial In Number: 201-689-8037 Conference ID # 13586309 If you are unable to participate, a replay of the conference call will be available for thirty days. Volmax Cr (Albuterol, Salbutamol) with free Rx The replay dial-in number for the U.S. Clopivas is 877-660-6853 and the dial-in number for international callers is 201-612-7415. Buy Motherwort online To access the replay you will need the conference ID number 13586309. The conference call will also be webcast live and can be accessed at .incyte.com under Investor Relations, Events and Webcasts. About Incyte Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary small molecule drugs primarily for oncology. http://asthmareview.wordpress.com For additional information on Incyte, please visit the Company s web site at .incyte.com.